TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Journal: Current Vascular Pharmacology
Guest Editor(s): Dr. Stefanos Roumeliotis
Co-Guest Editor(s): Vassilios Liakopoulos
Submission closes on:
31st December, 2025
Introduction
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, In this Thematic Issue, the novel proposed therapeutic options for the management of Cardiovascular disease in both CKD and ESKD are presented.
Keywords
Cardiovascular disease, Chronic Kidney Diseas?, End Stage Kidney Disease, Hemodialysis, Peritoneal Dialysis, Vascular Calcification